Followers | 1106 |
Posts | 279775 |
Boards Moderated | 10 |
Alias Born | 03/18/2011 |
Saturday, February 18, 2012 3:31:33 AM
~ $AMED ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=AMED&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=AMED&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=AMED
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=AMED#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=AMED+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=AMED
Finviz: http://finviz.com/quote.ashx?t=AMED
~ BusyStock: http://busystock.com/i.php?s=AMED&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=AMED >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent AMED News
- Amedisys Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/24/2024 08:45:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 06:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:03:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:02:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:01:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:00:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:59:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:58:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:49 PM
- Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results • GlobeNewswire Inc. • 02/21/2024 09:30:11 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:24:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:18:47 PM
- Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis • GlobeNewswire Inc. • 02/08/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 11:02:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 01:57:14 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2023 09:27:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/25/2023 12:00:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 11:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:31:38 PM
- Amedisys Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/24/2023 08:30:36 PM
- Amedisys Celebrates National Quality Week • GlobeNewswire Inc. • 10/18/2023 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:57:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 12:56:02 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/01/2023 09:14:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM